Evidence map›Paper›PMID 38667466›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify

Daniëlle de Jong, Cody Carrell, Jane K Maganga, Loyce Mhango, Peter S Shigella, Maddy Gill, Ryan Shogren, Brianna Mullins, Jay W Warrick, John M Changalucha and 4 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Daniëlle de JongDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0003-4003-5593
Cody CarrellSalus Discovery LLC, Madison, WI 53703, USA.
Jane K MagangaMwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania.
Loyce MhangoMwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania.
Peter S ShigellaMwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania.
Maddy GillSalus Discovery LLC, Madison, WI 53703, USA.
Ryan ShogrenSalus Discovery LLC, Madison, WI 53703, USA.
Brianna MullinsSalus Discovery LLC, Madison, WI 53703, USA.
Jay W WarrickSalus Discovery LLC, Madison, WI 53703, USA.ORCID 0000-0002-4801-8897
John M ChangaluchaMwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania.
Govert J van DamDepartment of Parasitology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Khanh PhamDivision of Infectious Diseases, Weill Cornell Medicine, New York, NY 10065, USA.
Jennifer A DownsMwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania.
Paul L A M CorstjensDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0002-0004-0526
Salus (United States) · USMwanza Intervention Trials Unit · TZLeiden University Medical Center · NLCornell University · US

Funding

Technology Training and Dissemination CoreU54EB027690 · NIBIB · EMORY UNIVERSITY · PI Wilbur A Lam, GREGORY S MARTIN · 2018 to 2026
$96.1M
T32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8M
Genital Immune, Mucosal, and Viral Effects of Female Genital Schistosomiasis in TanzaniaR01AI168306 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jennifer Alzos Downs · 2022 to 2026
$3.1M
Post-Doctoral Fellowship Training in HIV Clinical InvestigationD43TW011826 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI Daniel W Fitzgerald, Saidi Kapiga · 2021 to 2026
$1.9M
FIC NIH HHS D43 TW011826FIC NIH HHS T32 AI 007613NIAID NIH HHS R01 AI168306NIAID NIH HHS T32 AI007613NIBIB NIH HHS U54 EB027690NIBIB NIH HHS U54EB027690-03
6 · The paper itself

Abstract

A laboratory-based lateral flow (LF) test that utilizes up-converting reporter particles (UCP) for ultrasensitive quantification of

Indexed as

CAAcirculating anodic antigenequipment-freefield-deployablelateral flowLFPOCpoint-of-careSchistosomaUCPupconverting reporter particleurine diagnostics

Identifiers

PMID38667466
PMCPMC11048900
OpenAlexW4394837339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.